The European Commission has formally launched its strategy for accelerating the development and availability of safe and effective COVID-19 vaccines in a “timeframe between 12 and 18 months, if not earlier.”
The EU strategy for COVID-19 vaccines involves signing advance purchase agreements with companies to secure vaccine production in the EU...







